Blog

13 December, 2021

“The pandemic has shown that more Autonomous Communities can host clinical trials of drugs, which is hopeful for many patients”

More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]
17 November, 2021

The AEMPS publishes the memorandum of ethics committees for drug research

Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) […]
4 November, 2021

The MD Anderson Cancer Center in Madrid inaugurates one of the largest Phase I Clinical Trials units in Europe

Source: www.immedicohospitalario.es The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center […]
21 June, 2021

Farmaindustria estimates the investment in 2020 of pharmaceutical companies in research at 39,000 million

Source: www.actasanitaria.com Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the […]
8 June, 2021

The medicine, health, social and economic value

Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as […]
21 May, 2021

The investment of the pharmaceutical industry in R&D grows in 2020 despite the pandemic

Via: www.consalud.es The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This […]
20 May, 2021

Spain, a country of reference in conducting clinical trials

Via: www.immedicohospitalario.es Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new […]
10 May, 2021

The pharmaceutical industry has almost 90 drugs under development against antimicrobial resistance

Researchers at pharmaceutical companies are working to develop innovative antibacterial treatments, such as bacteriophages, live therapeutics, and monoclonal antibodies. The development period for new antimicrobials can […]
6 May, 2021

“Europe has the challenge of regaining ground lost to the US and Asia in drug research” “

In just two decades, the European Union has gone from leading global biomedical R&D to being the origin of only 23% of new drugs, while 47% […]
27 April, 2021

Digitization in clinical research advances for the benefit of patients

The pandemic has prompted the digitization of some clinical trial processes, but questions remain to be resolved in the globalized management of health data Farmaindustria defends […]
15 April, 2021

Observational studies with drugs published in the Spanish Trial Registry

  Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has communicated that Royal Decree 957/2020, of November 3, which regulates observational studies with […]
17 March, 2021

Spain launched 44 clinical trials for cardiovascular diseases in 2020

Pharmacological treatments, together with heart-healthy lifestyles, are the factors that contribute the most to improving the control of these pathologies The pharmaceutical industry has 600 investigational […]
11 March, 2021

Promoting the use of biomarkers improves cancer diagnosis and treatment

A new study evaluates the availability, quality and reimbursement of these tests in the European Union It proposes short and long-term measures to move towards precision […]
4 March, 2021

20% of clinical trials in Spain are already focused on rare diseases

The European Regulation on Orphan Medicines of the year 2000 has been the key in this research launch A quarter of the annual approvals of new […]
23 February, 2021

Clinical trials: this is how drugs and vaccines are designed

Medications and vaccines don’t come out of nowhere. They are not done in a rush and they are not due to commercial gimmicks. They are the […]
5 February, 2021

Cancer: the fight is not stopped by the covid; 4 out of 10 investigational drugs are antitumor

Source: https: www.diariofarma.com Cancer continues to be one of the main fronts of the fight for drug research. On the occasion of tomorrow’s World Cancer Day […]
26 January, 2021

CARTs effective for solid tumors, not just blood cancers

An American study indicates that these cells can fight breast, colon and lung cancer Source: www.redaccionmedica.com A new study, led by researchers at UT Southwestern (UTSW) […]
14 December, 2020

Why might the development of a new drug take more than 10 years?

Source: www.lne.es New drugs are responsible for 73% of the prolongation of life expectancy in developed countries and have managed to solve more and more diseases. […]
9 December, 2020

The pharmaceutical industry once again sets a record for investment in R&D in Spain

Source: www.lavozdegalicia.es The sector has registered an investment in research and development of 1,211 million euros in 2019, 5.2% more than the previous year In these […]
30 November, 2020

The Royal Decree that regulates observational studies with medicines for human use approved

Source: www.noticias.juridicas.com Royal Decree 957/2020, of November 3, establishes the conditions that must be met to proceed with the evaluation, performance and monitoring of observational studies […]
19 November, 2020

Eight drug projects of small Spanish companies attract the interest of pharmaceutical companies

New meeting of the Farma-Biotech program, which brings start-ups and research groups into contact with national and international pharmaceutical companies to promote preclinical research and facilitate […]
9 November, 2020

Regulatory alignment and mutual recognition for the manufacture of medicines, needs of the pharmaceutical industry in the face of ‘Brexit’

Pharmaceutical companies are working to ensure seamless access to medicines ahead of the UK’s exit from the EU, due in January Farmaindustria and the British Embassy […]
6 November, 2020

Takeda launches a website that groups all its clinical trials

So, in an exercise of transparency, anyone can have access to this data Carmen Montoto, Takeda Medical Director in Spain Source: www.redaccionmedica.com As part of its […]
23 October, 2020

Farmaindustria bets on digitization to consolidate Spain in drug trials

In the workshop “Digital challenges in the management of clinical trials”, organized by Farmaindustria, its attendees have shown their commitment to digitization to help Spain consolidate […]
21 October, 2020

BMS celebrates the first international forum aimed at the research community of Spain and Portugal

The objective of this meeting has been to present the latest advances in the area of Oncology with experts of national and international origin and to […]
20 October, 2020

Research in breast cancer: more survival and better quality of life

Nine out of ten women diagnosed in Spain survive to 5 years The development of more precise, effective treatments with fewer side effects, together with the […]
5 October, 2020

Covid-19 has delayed cancer clinical trial programs

  Source: www.redaccionmedica.com María Blasco recalls that investment in science “is not even at the levels prior to 2010” Scientists gathered at the meeting ‘A new […]
2 October, 2020

Immunotherapy before surgery doubles survival in lung cancer

A Spanish study “opens a door in a global therapeutic approach” that would allow more patients to be cured Source: www.redaccionmedica.com The survival prospects of patients […]
28 September, 2020

The fight against cancer is not stopped by the coronavirus: four out of ten new investigational drugs are antitumor

Even in the harshest months of the pandemic, pharmaceutical companies have continued to promote studies to admit patients, when it was the only therapeutic alternative for […]
17 September, 2020

Comprehensive commitment of the pharmaceutical industry to patient safety

Clinical trials, pharmacovigilance and verification are just some of the fields of action where pharmaceutical companies actively work to guarantee the well-being of people in their […]
2 February, 2024

The Innovative Medicines Platform sets its roadmap for 2024 with the aim of turning Spain into a major biomedical innovation hub

The Technological Platform for Innovative Medicines – whose Coordination Committee is made up of 10 representatives from the pharmaceutical industry and 10 representatives from public research […]
1 February, 2024

A common catalogue of biomarkers in the National Health System is a great step forward for patients because it improves access to personalised medicine.

Farmaindustria welcomes the presentation by the Ministry of Health of the harmonised catalogue of genetic tests for the whole country. For this catalogue to become a […]
30 January, 2024

Frank R. Lichtenberg, Professor at Columbia University: “Life expectancy of cancer patients in Spain has increased by almost three years in the last decade thanks to the use of innovative drugs”.

The US expert unpacked the data from his study on the relationship between pharmaceutical innovation and cancer mortality in Spain between 1999 and 2016 in a […]
15 January, 2024

FDA approves 55 new drugs in 2023, one of the highest numbers in a decade

Infectious diseases, neurological diseases, type 2 diabetes in children, oncology and cardiac disorders are just some of the areas that benefited from the innovation drive last […]
11 January, 2024

The Distefar team is environmentally conscious and switches from buying single-use plastic bottles to glass bottles.

8 January, 2024

The pharmaceutical industry, a strategic sector for Spain and Europe

“We are the industrial area that invests the most in R&D, a productive and exporting engine”. larazon.es Developing and producing new medicines for society is both […]
21 December, 2023

Paediatricians join project to boost clinical research in primary care

The working group led by Farmaindustria holds a new meeting, with the participation of two new pharmaceutical companies. Farmaindustria.es The drive for clinical research in Primary […]
19 December, 2023

R&D investment in the pharmaceutical industry reaches 1.4 billion euros in Spain and grows by 10% in just one year

Of the €1.395 billion registered in 2022, 60% was devoted to clinical trial development. One out of every eight euros is already spent on basic and […]
11 December, 2023

“The European Health Data Space is an opportunity to gain greater efficiency in cancer drug research”.

Farmaindustria participates in the Medical Oncology, Haematology and Oncohaematology Pharmacy Congress ‘Building Bridges’, where data management in biomedical research was discussed. Farmaindustria.es “The proposed Regulation for […]
1 December, 2023

“Clinical trials are a hope for patients with rare diseases and already account for 25% of all research done in Spain”.

Farmaindustria’s CEO, Juan Yermo, participates in the conference ‘Towards a Comprehensive European Plan: Spain’s involvement with Rare Diseases’, organised by Feder in the Spanish Congress of […]
27 November, 2023

Boosting clinical research in Primary Care, an opportunity for patients, professionals and the health system

Farmaindustria presents the ‘Guide of good practice recommendations for the promotion of clinical research in Primary Care’, which will bring new treatment opportunities to patients in […]
21 November, 2023

“The European Health Data Space is a unique opportunity that will improve research and innovation for the whole of society.

The director of Farmaindustria’s Research Department participates in a round table on the regulation of this project held at the European Parliament Office in Madrid. “For […]